Global X S&P Biotech ETF
CURE
- A$65.57
- 0.98
- 1.52%
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Young & Invested: Do you need both IVV and NDQ in your portfolio?
A closer look at the illusion of choice in a concentrated market.
etfs
Top-rated global real estate ETF
Delivering value through a distinctive, standout approach to global real estate investing.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,174.10 | 12.00 | 0.13% |
| CAC 40 | 8,337.54 | 87.59 | -1.04% |
| DAX 40 | 24,444.33 | 257.91 | -1.04% |
| Dow JONES (US) | 49,377.19 | 70.24 | -0.14% |
| FTSE 100 | 10,604.89 | 62.74 | -0.59% |
| HKSE | 26,361.07 | 200.74 | 0.77% |
| NASDAQ | 24,314.80 | 153.68 | -0.63% |
| Nikkei 225 | 58,824.89 | 348.99 | 0.60% |
| NZX 50 Index | 12,915.45 | 9.78 | 0.08% |
| S&P 500 | 7,099.40 | 26.66 | -0.37% |
| S&P/ASX 200 | 8,953.30 | 13.60 | 0.15% |
| SSE Composite Index | 4,082.13 | 30.70 | 0.76% |